Congressionally directed medical research
CDMRP funding: the disease-specific money most companies miss
CDMRP is one of the largest sources of medical research funding in the United States, and one of the least understood outside academia. Congress names the diseases, patient advocates sit on the review panels, and nearly every mechanism gates on a pre-application that closes months before the full deadline.
The short answer
The Congressionally Directed Medical Research Programs are a Department of Defense funding portfolio, managed by the US Army Medical Research and Development Command, that awards grants against disease-specific programs named each year by Congress. Applications go through two review tiers — scientific peer review and programmatic review — with patient advocates serving as voting consumer reviewers on both. Companies, universities and non-profits are all eligible, subject to the terms of each mechanism.
- Set by Congress
- Annual appropriations name the disease and health programs funded.
- Two-tier review
- Scientific merit first, then programmatic fit against the portfolio.
- Pre-application gate
- Most mechanisms require one, weeks or months before the full deadline.
Programs, mechanisms and deadlines change every appropriation cycle. Confirm current opportunities at cdmrp.health.mil funding opportunities.
The award mechanisms, and what each rewards
Choosing the wrong mechanism is the most expensive mistake in CDMRP. Names and terms vary between programs, but most portfolios offer versions of these.
Idea and concept awards
Fund early, untested but high-impact hypotheses. Preliminary data is often not required, and in some mechanisms not even permitted. Innovation and impact carry the score.
Investigator-initiated research awards
The workhorse mechanism: a defined hypothesis with supporting preliminary data, usually over three to four years, sometimes with a partnering-PI option.
Translational and technology development awards
Move a finding toward a product or a clinical decision. These reward a clear translational endpoint and a credible regulatory and manufacturing view.
Clinical trial awards
Fund trials from small feasibility studies to multi-site work. Regulatory readiness, statistical power and site commitments are examined closely.
Career development and early-career awards
Support investigators at defined career stages, usually with a mentorship plan that gets scored as seriously as the science.
Consortium and network awards
Fund multi-institution teams tackling a program-level problem, with governance, data sharing and shared resources written into the plan.
How CDMRP reviewers score an application
Impact on the disease and the military community
Every CDMRP program exists because Congress named it. The application must connect the work to that program's stated goals and, where relevant, to service members, veterans and their families.
Innovation over incremental progress
Several mechanisms explicitly reward risk. A safe extension of your last paper will score well scientifically and lose on impact.
Language a consumer reviewer can follow
Lay abstracts and public impact statements are read by patient advocates who vote. These sections deserve as much drafting time as the research strategy.
Programmatic fit
The second review tier asks whether funding this application advances the portfolio, not just whether the science is sound. Excellent applications get declined for poor fit every year.
What a competitive CDMRP application needs
- The right program and the right mechanism for your stage
- A pre-application submitted on time through eBRAP
- A lay abstract a patient advocate can follow and champion
- A stated impact on the disease and, where relevant, military health
- A research strategy matched to the mechanism's evidence expectations
- Letters, sites and collaborators secured before the deadline
Many life-science companies run CDMRP alongside an NIH SBIR: the SBIR funds the commercial feasibility work, and the CDMRP award funds the disease-specific science that makes the product matter. See how NIH SBIR fits.
How we work on a CDMRP application
01
Program and mechanism selection
We match your work to the right CDMRP program and, just as importantly, the right mechanism within it. Choosing wrongly here wastes the whole cycle.
02
Pre-application
Almost every mechanism gates on a pre-application. We write it to the program's stated goals so you clear the gate and keep your place in the cycle.
03
Full application
Research strategy, statistical plan, impact statements and the lay abstract, drafted with your team and reviewed internally the way a CDMRP panel scores.
04
Submission and post-award
eBRAP and Grants.gov submission, formatting compliance, and support with reporting once the award lands.
The people who write your application
Jessica Vernon
Lead Innovation Consultant
Dr Thomas Kelly
Lead Innovation Consultant
Dr Felix Warren
Lead Innovation Consultant
CDMRP questions researchers and founders ask us
What is CDMRP?
The Congressionally Directed Medical Research Programs are a Department of Defense funding portfolio created in 1992. Congress appropriates money each year to named disease and health programs — breast cancer, prostate cancer, tuberous sclerosis, traumatic brain injury, chronic pain and many more — and CDMRP manages the competitions through the US Army Medical Research and Development Command.
Who can apply for CDMRP funding?
Applications are accepted from academic institutions, non-profits, for-profit companies, and government and military organisations, in the United States and often internationally, depending on the program announcement. Eligibility is set per mechanism, and some awards are restricted by career stage or require a specific partnership.
How is CDMRP different from NIH funding?
CDMRP portfolios are set by Congress against specific diseases and military health priorities rather than by scientific field. Review is two-tier: scientific peer review followed by programmatic review that weighs fit against the program's stated goals, and patient advocates sit on both panels as consumer reviewers with a real vote.
What is a consumer reviewer?
A consumer reviewer is a patient, survivor or family member who serves on the review panel alongside scientists. They judge how much the proposed work matters to people living with the condition. Applications that cannot explain their impact in accessible language lose ground at this stage.
How much funding do CDMRP awards provide?
Award sizes vary enormously by mechanism, from small idea or concept awards through to multi-million-dollar clinical trial and consortium awards. Each program announcement states the funding ceiling, period of performance and allowable costs for that mechanism.
When are CDMRP deadlines?
Most programs run on an annual cycle with pre-application deadlines in the spring and summer and full applications a few weeks later. Nearly every mechanism requires a pre-application, and missing it closes the door for that year, so the calendar matters more here than almost anywhere else in federal funding.
Free download
NSF SBIR Phase I readiness checklist and federal deadline calendar
Two pages, no email required. Every registration, eligibility test and proposal section you need before you write, plus the next deadline for NSF, NIH, DoD, DOE, NASA and USDA with the date you realistically need to start.
- 37-point readiness checklist
- Six agency deadlines with lead times
Planning a CDMRP application?
Book a free consultation and we will check the current program list against your disease area and tell you which mechanism fits.